Nektar Therapeutics (NASDAQ:NKTR)

20.35
Delayed Data
As of 3:59pm ET
 -0.64 / -3.03%
Today’s Change
15.64
Today|||52-Week Range
47.11
-38.10%
Year-to-Date
How Sweet Were Nektar Therapeutics' Q3 Results?
Nov 07 / MotleyFool.com - Paid Partner Content
Nektar Therapeutics (NKTR) Q3 2019 Earnings Call Transcript
Nov 07 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close20.98
Today’s open21.00
Day’s range20.28 - 21.34
Volume3,223,256
Average volume (3 months)3,366,664
Market cap$3.5B
Data as of 3:59pm ET, 11/12/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-169.12%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+287.81%
P/E ratioNM
Price/Sales4.96
Price/Book1.98

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...+0.14+0.20%
MORMorphoSys AG-0.57-2.13%
BLUEbluebird bio Inc+3.29+4.51%
IMMUImmunomedics Inc+0.20+1.16%
Data as of 4:00pm ET, 11/12/2019

Financials

Next reporting dateFebruary 25, 2020
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$1.2B
Annual profit (last year)$681.3M
Net profit margin57.09%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Francisco, California

Forecasts